Long-term inducible expression in striatal neurons from helper virus-free HSV-1 vectors that contain the tetracycline-inducible promoter system

Brain Research

Volumn 1083, Issue 1, 2006, Pages 1-13

  Gao, Qingshen ^a   Sun, Mei ^a   Wang, Xiaodan ^a   Zhang, Guo rong ^a   Geller, Alfred I ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Herpes Simplex Virus vector; Long term expression; Neuronal specific expression; Regulated expression; Striatal neuron; Tetracycline inducible promoter system

Indexed keywords

BETA GALACTOSIDASE; TETRACYCLINE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL LINE; CORPUS STRIATUM; FIBROBLAST; GENE EXPRESSION; GENE TRANSFER; HELPER VIRUS; HERPES SIMPLEX VIRUS 1; NERVE CELL; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; TRANSCRIPTION REGULATION; VIRUS EXPRESSION;

ANIMALS; CORPUS STRIATUM; CRICETINAE; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELPER VIRUSES; HERPESVIRUS 1, HUMAN; LAC OPERON; MALE; NEUROFILAMENT PROTEINS; NEURONS; PC12 CELLS; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; REGULATORY ELEMENTS, TRANSCRIPTIONAL; REPRESSOR PROTEINS; TIME FACTORS;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 33645958918     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.01.124     Document Type: Article

References (66)

1. Bahi A., Boyer F., Kafri T., and Dreyer J.L. CD81-induced behavioural changes during chronic cocaine administration: in vivo gene delivery with regulatable lentivirus. Eur. J. Neurosci. 19 (2004) 1621-1633
2. Baron U., Freundlieb S., Gossen M., and Bujard H. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res. 23 (1995) 3605-3606
3. Bhattacharjee A.K., Ueyama T., Kondoh T., Hayashi S., Abouelfetouh A., Sakai N., Saito N., and Kohmura E. In vivo transgene expression using an adenoviral tetracycline-regulated system with neuron-specific enolase promoter. Biochem. Biophys. Res. Commun. 317 (2004) 1144-1148
4. Bornkamm G.W., Berens C., Kuklik-Roos C., Bechet J.M., Laux G., Bachl J., Korndoerfer M., Schlee M., Holzel M., Malamoussi A., Chapman R.D., Nimmerjahn F., Mautner J., Hillen W., Bujard H., and Feuillard J. Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res. 33 (2005) e137
5. Bowers W.J., Olschowka J.A., and Federoff H.J. Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy. Gene Ther. 10 (2003) 941-945
6. Chen J., Bezdek T., Chang J., Kherzai A.W., Willingham T., Azzara M., and Nisen P.D. A glial-specific, repressible, adenovirus vector for brain tumor gene therapy. Cancer Res. 58 (1998) 3504-3507
7. Chtarto A., Bender H.U., Hanemann C.O., Kemp T., Lehtonen E., Levivier M., Brotchi J., Velu T., and Tenenbaum L. Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther. 10 (2003) 84-94
8. Corti O., Sanchez-Capelo A., Colin P., Hanoun N., Hamon M., and Mallet J. Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12120-12125
9. Fitzsimons H.L., McKenzie J.M., and During M.J. Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther. 8 (2001) 1675-1681
10. Folliot S., Briot D., Conrath H., Provost N., Cherel Y., Moullier P., and Rolling F. Sustained tetracycline-regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno-associated viral vector. J. Gene Med. 5 (2003) 493-501
11. Fotaki M.E., Pink J.R., and Mous J. Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer. Gene Ther. 4 (1997) 901-908
12. Fraefel C., Song S., Lim F., Lang P., Yu L., Wang Y., Wild P., and Geller A.I. Helper virus-free transfer of Herpes Simplex Virus type 1 plasmid vectors into neural cells. J. Virol. 70 (1996) 7190-7197
13. Furth P.A., St Onge L., Boger H., Gruss P., Gossen M., Kistner A., Bujard H., and Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9302-9306
14. Georgievska B., Jakobsson J., Persson E., Ericson C., Kirik D., and Lundberg C. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector. Hum. Gene Ther. 15 (2004) 934-944
15. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 5547-5551
16. Gossen M., and Bujard H. Studying gene function in eukaryotes by conditional gene inactivation. Annu. Rev. Genet. 36 (2002) 153-173
17. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., and Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 268 (1995) 1766-1769
18. Haberman R.P., McCown T.J., and Samulski R.J. Inducible long-term gene expression in brain with adeno-associated virus gene transfer. Gene Ther. 5 (1998) 1604-1611
19. Hall C.V., Jacob P.E., Ringold G.M., and Lee F. Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J. Mol. Appl. Genet. 2 (1983) 101-109
20. Harding T.C., Geddes B.J., Noel J.D., Murphy D., and Uney J.B. Tetracycline-regulated transgene expression in hippocampal neurones following transfection with adenoviral vectors. J. Neurochem. 69 (1997) 2620-2623
21. Harding T.C., Geddes B.J., Murphy D., Knight D., and Uney J.B. Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nat. Biotechnol. 16 (1998) 553-555
22. Herrlinger U., Pechan P.A., Jacobs A.H., Woiciechowski C., Rainov N.G., Fraefel C., Paulus W., and Reeves S.A. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression. J. Gene Med. 2 (2000) 379-389
23. Ho D.Y., McLaughlin J.R., and Sapolsky R.M. Inducible gene expression from defective Herpes Simplex Virus vectors using the tetracycline-responsive promoter system. Mol. Brain Res. 41 (1996) 200-209
24. Hofmann A., Nolan G.P., and Blau H.M. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5185-5190
25. Hwang J.J., Scuric Z., and Anderson W.F. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system. J. Virol. 70 (1996) 8138-8141
26. Jiang L., Rampalli S., George D., Press C., Bremer E.G., O'Gorman M.R., and Bohn M.C. Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR. Gene Ther. 11 (2004) 1057-1067
27. Jin B.K., Belloni M., Conti B., Federoff H.J., Starr R., Son J.H., Baker H., and Joh T.H. Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective Herpes Simplex Virus amplicon vector. Hum. Gene Ther. 7 (1996) 2015-2024
28. Johnson P.A., Miyanohara A., Levine F., Cahill T., and Friedmann T. Cytotoxicity of a replication-defective mutant of Herpes Simplex Virus type 1. J. Virol. 66 (1992) 2952-2965
29. Johnson P.A., Yoshida K., Gage F.H., and Friedmann T. Effects of gene transfer into cultured CNS neurons with a replication-defective Herpes Simplex Virus type 1 vector. Mol. Brain Res. 12 (1992) 95-102
30. Johnson P.A., Wang M.J., and Friedmann T. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of Herpes Simplex Virus type 1 but not by mutation of the virion host shutoff function. J. Virol. 68 (1994) 6347-6362
31. Kafri T., van Praag H., Gage F.H., and Verma I.M. Lentiviral vectors: regulated gene expression. Mol. Ther. 1 (2000) 516-521
32. Kaplitt M.G., Kwong A.D., Kleopoulos S.P., Mobbs C.V., Rabkin S.D., and Pfaff D.W. Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8979-8983
33. Koponen J.K., Kankkonen H., Kannasto J., Wirth T., Hillen W., Bujard H., and Yla-Herttuala S. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Ther. 10 (2003) 459-466
34. Lamartina S., Silvi L., Roscilli G., Casimiro D., Simon A.J., Davies M.E., Shiver J.W., Rinaudo C.D., Zampaglione I., Fattori E., Colloca S., Gonzalez Paz O., Laufer R., Bujard H., Cortese R., Ciliberto G., and Toniatti C. Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates. Mol. Ther. 7 (2003) 271-280
35. Lee Y.B., Cosgrave A.S., Glover C.P., Bienemann A., Heywood D., Hobson R.J., and Uney J.B. Increased utility in the CNS of a powerful neuron-specific tetracycline-regulatable adenoviral system developed using a post-transcriptional enhancer. J. Gene Med. 7 (2005) 576-583
36. Lim F., Hartley D., Starr P., Lang P., Song S., Yu L., Wang Y., and Geller A.I. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques 20 (1996) 460-469
37. Mansuy I.M., and Bujard H. Tetracycline-regulated gene expression in the brain. Curr. Opin. Neurobiol. 10 (2000) 593-596
38. Markusic D., Oude-Elferink R., Das A.T., Berkhout B., and Seppen J. Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res. 33 (2005) e63
39. Matsuura N., Lie D.C., Hoshimaru M., Asahi M., Hojo M., Ishizaki R., Hashimoto N., Noji S., Ohuchi H., Yoshioka H., and Gage F.H. Sonic hedgehog facilitates dopamine differentiation in the presence of a mesencephalic glial cell line. J. Neurosci. 21 (2001) 4326-4335
40. Olschowka J.A., Bowers W.J., Hurley S.D., Mastrangelo M.A., and Federoff H.J. Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol. Ther. 7 (2003) 218-227
41. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, Sidney
42. Regulier E., Pereira de Almeida L., Sommer B., Aebischer P., and Deglon N. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum. Gene Ther. 13 (2002) 1981-1990
43. Schmeisser F., Donohue M., and Weir J.P. Tetracycline-regulated gene expression in replication-incompetent Herpes Simplex Virus vectors. Hum. Gene Ther. 13 (2002) 2113-2124
44. Shockett P., Difilippantonio M., Hellman N., and Schatz D.G. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 6522-6526
45. Smith I.L., Hardwicke M.A., and Sandri-Goldin R.M. Evidence that the Herpes Simplex Virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 186 (1992) 74-86
46. Song S., Wang Y., Bak S.Y., Lang P., Ullrey D., Neve R.L., O'Malley K.L., and Geller A.I. An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J. Neurochem. 68 (1997) 1792-1803
47. Stevens J.G. Latent Herpes Simplex Virus and the nervous system. Curr. Top. Microbiol. Immunol. 70 (1975) 31-50
48. Sun M., Zhang G.R., Yang T., Yu L., and Geller A.I. Improved titers for helper virus-free Herpes Simplex Virus type 1 plasmid vectors by optimization of the packaging protocol and addition of noninfectious Herpes Simplex Virus-related particles (previral DNA replication enveloped particles) to the packaging procedure. Hum. Gene Ther. 10 (1999) 2005-2011
49. Sun M., Zhang G., Kong L., Holmes C., Wang X., Zhang W., Goldstein D.S., and Geller A.I. Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free Herpes Simplex Virus type 1 vector. Hum. Gene Ther. 14 (2003) 415-424
50. Sun M., Kong L., Wang X., Holmes C., Gao Q., Zhang W., Pfeilschifter J., Goldstein D.S., and Geller A.I. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter-2 from a helper virus-free HSV-1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease. Hum. Gene Ther. 15 (2004) 1177-1196
51. Sun M., Kong L., Wang X., Lu X., Gao Q., and Geller A.I. Comparison of protection of nigrostriatal neurons by expression of GDNF, BDNF, or both neurotrophic factors. Brain Res. 1052 (2005) 119-129
52. Toniatti C., Bujard H., Cortese R., and Ciliberto G. Gene therapy progress and prospects: transcription regulatory systems. Gene Ther. 11 (2004) 649-657
53. Urlinger S., Baron U., Thellmann M., Hasan M.T., Bujard H., and Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7963-7968
54. Utomo A.R., Nikitin A.Y., and Lee W.H. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat. Biotechnol. 17 (1999) 1091-1096
55. Vogel R., Amar L., Thi A.D., Saillour P., and Mallet J. A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain. Hum. Gene Ther. 15 (2004) 157-165
56. Wade-Martins R., Saeki Y., and Chiocca E.A. Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells. Mol. Ther. 7 (2003) 604-612
57. Wang Y., Yu L., and Geller A.I. Diverse stabilities of expression in the rat brain from different cellular promoters in a helper virus-free Herpes Simplex Virus type 1 vector system. Hum. Gene Ther. 10 (1999) 1763-1771
58. Wang X., Zhang G., Yang T., Zhang W., and Geller A.I. Fifty-one kilobase HSV-1 plasmid vector can be packaged using a helper virus-free system and supports expression in the rat brain. BioTechniques 27 (2000) 102-106
59. Wang X., Zhang G., Sun M., and Geller A.I. General strategy for constructing large HSV-1 plasmid vectors that co-express multiple genes. BioTechniques 31 (2001) 204-212
60. Wang J.J., Niu D.B., Zhang T., Wang K., Xue B., and Wang X.M. A tetracycline-regulatable adeno-associated virus vector for double-gene transfer. Neurosci. Lett. 378 (2005) 106-110
61. Wilsey J., Zolotukhin S., Prima V., Shek E.W., Matheny M.K., and Scarpace P.J. Hypothalamic delivery of doxycycline-inducible leptin gene allows for reversible transgene expression and physiological responses. Gene Ther. 9 (2002) 1492-1499
62. Wood M.J., Byrnes A.P., Pfaff D.W., Rabkin S.D., and Charlton H.M. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther. 1 (1994) 283-291
63. Yang T., Zhang G., Zhang W., Sun M., Wang X., and Geller A.I. Enhanced reporter gene expression in the rat brain from helper virus-free HSV-1 vectors packaged in the presence of specific mutated HSV-1 proteins that affect the virion. Mol. Brain Res. 90 (2001) 1-16
64. Yu J.S., Sena-Esteves M., Paulus W., Breakefield X.O., and Reeves S.A. Retroviral delivery and tetracycline-dependent expression of IL-1beta-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells. Cancer Res. 56 (1996) 5423-5427
65. Zhang W., and Geller A. In Chinese: comparison of the immune response to gene transfer into the rat brain with helper or helper virus-free HSV-1 vectors. Huaxi Yide Daxue Xuebao 33 (2002) 175-178
66. Zhang G., Wang X., Yang T., Sun M., Zhang W., Wang Y., and Geller A.I. A tyrosine hydroxylase-neurofilament chimeric promoter enhances long-term expression in rat forebrain neurons from helper virus-free HSV-1 vectors. Mol. Brain Res. 84 (2000) 17-31